Ablation therapy for hepatocellular carcinoma: past, present and future perspectives

DJ Niemeyer, KA Simo, DA Iannitti, IH McKillop - Hepatic Oncology, 2014 - Taylor & Francis
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and
is most commonly found in the setting of liver cirrhosis. Treatment of HCC must consider …

[PDF][PDF] Percutaneous ablation of hepatocellular carcinoma: state‐of‐the‐art

R Lencioni, D Cioni, L Crocetti… - Liver …, 2004 - Wiley Online Library
Percutaneous ablation is considered the best treatment option for patients with early‐stage
hepatocellular carcinoma (HCC) who are not candidates for surgical resection or liver …

Local ablation therapy for hepatocellular carcinoma: current status and future perspectives

M Kudo - Journal of gastroenterology, 2004 - search.proquest.com
Local ablation therapy is one of the best curative treatment options for hepatocellular
carcinoma, and can be an alternative to resection. Generally, attempting local complete cure …

[HTML][HTML] Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative …

PS Koh, ACY Chan, TT Cheung, KSH Chok, WC Dai… - HPB, 2016 - Elsevier
Background This study aims to assess if radiofrequency ablation (RFA) has any oncological
superiority over transarterial chemoembolization (TACE) on post-hepatectomy recurrence …

[PDF][PDF] Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?

ACY Chan, SC Chan, KSH Chok… - Liver …, 2013 - Wiley Online Library
The objective of this study was to evaluate the efficacy of salvage liver transplantation (SLT),
repeated hepatic resection (RR), and repeated radiofrequency ablation (rRFA) for patients …

State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma

U Salati, A Barry, FY Chou, R Ma, DM Liu - Future Oncology, 2017 - Taylor & Francis
Primary liver cancer, mainly hepatocellular carcinoma, is one of the most common
malignancies worldwide. Surgical management, either resection or transplantation, is …

The current role of radiofrequency ablation in the treatment of intrahepatic recurrent hepatocellular carcinoma

R Fu, W Ling - Journal of Surgical Oncology, 2023 - Wiley Online Library
The incidence of recurrent hepatocellular carcinoma (HCC) after initial curative treatments is
relatively high. However, there is still the lack of standard management of recurrent HCC …

Locally ablative therapies of hepatocellular carcinoma

JW Sturm, MA Keese, RG Bönninghoff, M Wüstner… - Onkologie, 2001 - europepmc.org
Locally Ablative Therapies of Hepatocellular Carcinoma Delayed diagnosis of
hepatocellular carcinomas (HCC) leads to a poor prognosis with a median survival time of …

Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis

Y Yang, H Yu, X Tan, Y You, F Liu, T Zhao… - International Journal …, 2021 - Taylor & Francis
Background & aims Liver resection (LR) and radiofrequency ablation (RFA) are commonly
used for the treatment of recurrent hepatocellular carcinoma (HCC), but the optimal …

Hepatocellular carcinoma: the role of interventional oncology

M Donadon, L Solbiati, L Dawson, A Barry… - Liver cancer, 2017 - karger.com
Background: Hepatocellular carcinoma (HCC) remains a major health issue because of its
increasing incidence and because of the complexity of its management. In addition to the …